Volume 9, Issue 3, April 2023

A tailor-made suit always fits best

• Extract
• View article

Antithrombotic therapy following revascularization for chronic limb-threatening ischaemia: a European survey from the ESC Working Group on Aorta and Peripheral Vascular Diseases

• Abstracts
• View article
• Supplementary data

Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation

• Abstracts
• View article
• Supplementary data

Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials

• Abstracts
• View article
• Supplementary data

The effect of a Prasugrel- vs. a Ticagrelor-based strategy on total ischaemic and bleeding events in patients with acute coronary syndromes

• Abstract
• View article
• Supplementary data

Efficacy and safety of P2Y₁₂ inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysis

• Abstracts
• View article
• Supplementary data

Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials

• Abstracts
• View article
• Supplementary data

Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial

• Abstract
• View article
• Supplementary data

Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)

• Abstracts
• View article
• Supplementary data

Corrigendum to: Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

• Extract
• View article

Corrigendum to: Digoxin use in contemporary heart failure with reduced ejection fraction: An analysis from the Swedish Heart Failure Registry

• Extract
• View article

Corrigendum to: Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: A nationwide registry analysis

• Extract
• View article